Professor David Keegan

Our Retina International World Congress (RIWC24) takes place from the 5th – 8th June 2024 in the Dublin Royal Convention Centre, in the heart of Dublin city centre.

Our Scientific Committee has been working relentlessly to secure an impressive lineup of outstanding speakers to shed light on this research area so as part of our Meet the Speaker series, we are delighted to announce one more distinguished speaker.

Professor David Keegan is a Consultant Ophthalmologist at the Mater Misericordiae University Hospital.

We are delighted to have Professor David Keegan with us at the Retina International World Congress:

Image description: Headshot of Prof. David Keegan on a blue background image. Text: Retina International World Congress. Dublin Royal Convention Centre, Dublin, Ireland. RIWC24. DUBLIN: Targeting the Cure. JUNE 5-8, 2024. PROF. DAVID KEEGAN, Consultant Οphthalmologist, Mater Misericordiae University Hospital. At the bottom of the image, there are the Fighting Blindness and Retina International logos.

Mr Keegan, (MB BCh BAO; LRCP&SI; MMedSc (Anat); FRCSI(Oph); FRCOphth; PhD), completed his basic and higher ophthalmology surgical training at Moorfield’s Eye Hospital, London (1997-2005). He completed his Fellowship in Vitreo-retinal surgery at Columbia University / New York Presbyterian Hospital, New York, USA (2005-2006).

Mr Keegan’s areas of special interest include inherited retinal degeneration, diabetic retinopathy, retinal transplantation (immunological consequences), health economics, low-vision device development, biomarkers in age-related macular degeneration, retinal detachment, retinal repair and regeneration.

In addition to his role as consultant vitreo-retinal surgeon, Mater Hospital, Mr Keegan also serves as:

  • National Clinical Lead for Diabetic Retinopathy, National Screening Service, NSS, Dublin
  • Honorary Consultant Vitreo-retinal Surgeon, Temple Street Children’s University Hospital, Dublin
  • Board Member of National Council for the Blind (NCBI) and Fighting Blindness Ireland Voluntar
  • Chair of the NCBI Vision 20/20 committee to develop a state of the art low vision assistance programme in Ireland.

His is involved in an active retina research group and we also strive to ensure that our basic sciences studies parallel those in the clinic and have run seven clinical trials.

He is involved in residency and fellow training and lectures at undergraduate and postgraduate level.

He is a member of Scientific and Medical Advisory Board for Retina International.

Stay tuned for more updates as we draw closer to this incredible gathering of the latest scientific research and innovation, set to take place in June 2024!

You can learn more about Professor David Keegan here.